Mealey's reported that more than 340 plaintiffs sued the makers, distributors and a retailer of Carefree feminine hygiene products in California court. The suit alleges the companies failed to protect consumers from or warn about PFOA, a PFAS chemical, and seeks an injunction, according to Mealey's Toxic Torts report. PFAS means per- and polyfluoroalkyl substances, often called forever chemicals. PFOA is one older member of that chemical family.
Official resources:
- Read the original report from Mealeys — Use this primary source to review the complete report.
- Read the official notice from Openclassactions — Use this primary source to verify the official announcement.
Table of Contents
- Can you file a claim now?
- Who is being sued?
- What harm do plaintiffs allege?
- What test and law sit at the center?
- What should buyers do?
Can you file a claim now?
No. This is not a class action with a settlement or claim form. OpenClassActions reports the case is Lindsey et al.
v. Edgewell Personal Care et al., filed Oct. 9-11, 2026 in Los Angeles County Superior Court as a strict-liability personal-injury action, according to its case summary. That status matters for readers looking for payment:.
- There is no proof-of-purchase form to submit.
- There is no payout amount or deadline.
- Each plaintiff must prove personal use, exposure and injury.
Who is being sued?
The defendants cover the brand's ownership chain. OpenClassActions reports they include Edgewell, owner from 2013 to February 2026, Essity, the current owner, Johnson & Johnson and Kenvue, tied to earlier ownership, plus retailer Gelson's Markets.
Edgewell completed the sale of its Feminine Care segment, including Carefree, Stayfree and o.b., to Sweden's Essity for $340 million on Feb. 2, 2026. That transfer explains why both Edgewell and Essity are named.
What harm do plaintiffs allege?
Manufacturing Dive reports plaintiffs allege daily liner wear exposed sensitive genital tissue to PFOA for long periods. They link that exposure to breast, ovarian and kidney cancers, thyroid disease, immune and inflammatory disorders, high cholesterol and reduced fertility, according to its lawsuit account.
They seek compensatory and punitive damages plus a court order. Those injuries are claims in a complaint, not court findings.
What test and law sit at the center?
The complaint points to a 2024 independent lab test that allegedly found PFOA in one or more of Carefree's five product layers. It also cites a Feb. 6, 2024 60-day notice to California prosecutors and alleges sales continued afterward.
California's TAMPON Act, AB 2515, signed Sept. 30, 2024, bars menstrual products with intentionally added PFAS from Jan. 1, 2025. SGS reports broader total-organic-fluorine limits are to be set by state regulators by 2027.
What should buyers do?
Treat this as a watched lawsuit, not a benefits program. Liability and causation are unproven, and the broad injury list remains allegation. The American Council on Science and Health also notes a separate Sept.
30, 2024 Ecological Alliance Proposition 65 warning suit against Edgewell is distinct from this case. For now, do not pay anyone to file for you. Save receipts, boxes and medical records, ask a licensed personal-injury lawyer about California deadlines, and follow the Los Angeles County docket for any certified class or settlement.